Medical Research News

RSS

Humana, Novo Nordisk enter research partnership to explore diabetes treatment and care

Humana Inc. and Novo Nordisk Inc. today announced a one-year research partnership to explore diabetes treatment and care. Together, researchers will identify opportunities to change how patients might be treated to improve quality and outcomes for the millions of people who battle diabetes.

18 Jun 2012

KineMed, GSK enter multi-year biomarker discovery partnership

KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.

18 Jun 2012

Zealand Pharma, Protagonist partner to develop novel disulfide-rich peptides

Zealand Pharma A/S, a Danish biotechnology company dedicated to the discovery and development of novel peptide drugs, has signed a collaboration agreement with Protagonist Therapeutics, Inc., a privately-owned US incorporated biotechnology company.

18 Jun 2012

PAREXEL launches fully-integrated eClinical solution

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of the PAREXEL MyTrials platform, a fully-integrated eClinical solution that simplifies the clinical trial process.

From Parexel 18 Jun 2012

Wellcome Trust awards University of Maryland $4M to accelerate development of conjugate NTS vaccine

The University of Maryland School of Medicine's Center for Vaccine Development (CVD) has received a $4 million Strategic Translation Award from the prestigious Wellcome Trust to support a collaboration with Bharat Biotech for clinical development of a new conjugate vaccine to prevent the potentially lethal infectious disease caused by invasive non-typhoidal Salmonella.

18 Jun 2012

Thermo Fisher Scientific introduces research-grade FT-IR system

Thermo Fisher Scientific Inc., the world leader in serving science, extended its leading FT-IR spectrometry platform by introducing the first research-grade FT-IR system designed for simple one-touch operation.

From Thermo Fisher Scientific Inc. 18 Jun 2012

Ambrx, Merck collaborate to develop and commercialize biotherapeutic drug conjugates

Ambrx today announced that the company has entered into a collaboration with Merck to design and develop rationally optimized biologic drug conjugates based on Ambrx's site-specific protein medicinal chemistry technology.

18 Jun 2012

First study to look at hotel room cleanliness

An experiment of surfaces in hotel rooms finds television remotes to be among the most heavily contaminated with bacteria and items on housekeeping carts carry the potential to cross-contaminate rooms. Researchers from the University of Houston report the findings today at the 2012 General Meeting of the American Society for Microbiology.

18 Jun 2012

Tobacco cessation must be included as part of standard clinical care for cancer patients

While tobacco use can significantly hamper cancer treatment, few cancer researchers are incorporating tobacco assessment into their clinical studies. That's the conclusion a group of investigators led by Graham Warren, MD, PhD, Assistant Professor in the Department of Radiation Medicine at Roswell Park Cancer Institute (RPCI), drew from a recent survey of cancer clinical trials.

16 Jun 2012

Study reveals value of graphic warning labels on cigarette packaging

In a first of its kind study in the U.S., researchers at the Perelman School of Medicine at the University of Pennsylvania have shown that the addition of graphic warning labels on cigarette packaging can improve smokers' recall of the warning and health risks associated with smoking. The new findings are published online-first in the American Journal of Preventive Medicine.

16 Jun 2012

CMS awards nearly $18 million to spread collaborative care model for managing depression

The Centers for Medicare and Medicaid Services (CMS) has awarded almost $18 million to a local and national collaboration of partner organizations with the Institute for Clinical Systems Improvement (ICSI) as lead organization.

16 Jun 2012

Surprising effects of brain injury

When Maria Ross' husband found his healthy and active wife unconscious on the bathroom floor, the pair had no idea they would embark on a journey into the world of brain injury, learning more about how trauma affects the brain - and your identity - than they ever cared to know.

16 Jun 2012

Latest allergy research presented at EAACI Congress 2012

Ground-breaking research results about stress during pregnancy and changes in pollen potency across Europe will be presented - among other novel research - at the world's leading congress on allergy and immunology - the EAACI Congress 2012 - that will open tomorrow in Geneva, Switzerland.

16 Jun 2012

'Tip-of-the-tongue' errors happen often to adults over 65

Has your memory failed you today, such as struggling to recall a word that's "on the tip of your tongue?" If so, you're not alone.

16 Jun 2012

Bristol-Myers Squibb, Scripps Research enter five-year collaboration

The Scripps Research Institute today announced it has entered into a five-year collaboration with Bristol-Myers Squibb Company focused on applying novel chemistry to drug discovery and synthesis.

16 Jun 2012

Social-class discrimination can contribute to physiologic changes associated with poorer health

Discrimination felt by teenagers based on their social class background can contribute to physiologic changes associated with poorer health, according to a new study led by a University of Wisconsin-Madison researcher.

16 Jun 2012

Psoriasis TNF-α therapeutic effects mediated by MSC antioxidant reduction

The therapeutic effects of tumor necrosis factor-α inhibitors in psoriasis occur through a reduction in the antioxidant response of mesenchymal stem cells, suggest study findings.

15 Jun 2012

Insulin more effective add-on than sitagliptin in glucose control

Insulin seems to be a more effective add-on regimen than sitagliptin in patients with diabetes inadequately controlled by metformin monotherapy, show study findings.

15 Jun 2012

Anti-TNFs increase risk for herpes zoster infections in IRD patients

Patients with inflammatory rheumatic diseases who are treated with anti-tumor necrosis factor medications are significantly more likely to experience herpes zoster infections than those treated with traditional disease-modifying anti-rheumatic drugs, study results show.

15 Jun 2012

Rheumatism drugs may increase shingles risk

Patients with inflammatory rheumatic disease treated with one of the most effective medicines for their disease face a substantially increased risk for developing shingles, warn European researchers who suggest vaccination may be an option.

15 Jun 2012